Wird geladen...
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
Satisfactory management of Parkinson’s disease is a challenge that requires a tailored approach for each individual. In the advanced phase of the disease, patients may experience motor complications despite optimized pharmacological therapy. Apomorphine, a short-acting D(1)- and D(2)-like receptor a...
Gespeichert in:
| Veröffentlicht in: | CNS Drugs |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776563/ https://ncbi.nlm.nih.gov/pubmed/31473980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00661-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|